CASI Stock Summary and Trading Ideas (Casi Pharmaceuticals - | NASDAQ:CASI)

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Casi Pharmaceuticals - trades on the NASDAQ stock market under the symbol CASI.

As of January 9, 2026, CASI stock price climbed to $1.10 with 109,669 million shares trading.

CASI has a beta of 0.62, meaning it tends to be less sensitive to market movements. CASI has a correlation of 0.01 to the broad based SPY ETF.

CASI has a market cap of $17.04 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CASI traded as high as $8.48 and as low as $.75.

CASI has underperformed the market in the last year with a return of -61.5%, while the SPY ETF gained +19.0%. In the last 3 month period, CASI fell short of the market, returning -46.3%, while SPY returned +3.7%. However, in the most recent 2 weeks CASI has outperformed the stock market by returning +39.3%, while SPY returned +0.5%.

CASI support price is $.97 and resistance is $1.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CASI shares will trade within this expected range on the day.